Table 2

Changes in kidney function parameters after 6 months for the total population (n=45) and the group with stable medication use (n=29) and after 12 months for the total population

Total population (n=45)T0T6T12
Mean±SD median (IQR)Mean±SD median (IQR)nP valueMean±SD median (IQR)nP value
 eGFR (mL/min/1.73 m2)62.0 (55.5–65.0)69.0 (55.0–76.5)370.002*63.5 (58.5–71.0)220.067
 Albumin/creatinine ratio1.0 (0.4–1.8)0.9 (0.5–3.0)260.2621.0 (0.2–2.7)180.286
 HbA1c (%)7.3±3.17.1±3.4430.1377.4±3.4240.361
Blood pressure (mmHg)
 BMI (kg/m2)32.1±4.229.3±4.044<0.001*29.0±3.729<0.001*
 Group with stable medication use (n=29)Mean±SD median (IQR)Mean±SD median (IQR)nP valueN/A
 eGFR (mL/min/1.73 m2)62.0 (59.5–66.0)69.0 (60.0–77.0)250.006*
 Albumin/creatinine ratio1.1 (0.3–3.1)0.9 (0.2–4.0)260.249
 HbA1c (%)7.2±3.17.0±3.5270.248
Blood pressure (mmHg)
 BMI (kg/m2)31.5±4.028.8±4.029<0.001*
  • *Significant result.

  • †MAP calculated as: (SBP+2(DBP))/3.

  • BMI, body mass index; DBP, diastolic blood pressure; IQR, interquartile range; MAP, mean arterial pressure; NA, not available; SBP, systolic blood pressure; SD, standard deviation.